These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 30150001)

  • 21. Metformin: A Promising Antidiabetic Medication for Cancer Treatment.
    Mu W; Jiang Y; Liang G; Feng Y; Qu F
    Curr Drug Targets; 2023; 24(1):41-54. PubMed ID: 36336804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex.
    Howell JJ; Hellberg K; Turner M; Talbott G; Kolar MJ; Ross DS; Hoxhaj G; Saghatelian A; Shaw RJ; Manning BD
    Cell Metab; 2017 Feb; 25(2):463-471. PubMed ID: 28089566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current understanding of metformin effect on the control of hyperglycemia in diabetes.
    An H; He L
    J Endocrinol; 2016 Mar; 228(3):R97-106. PubMed ID: 26743209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An energetic tale of AMPK-independent effects of metformin.
    Miller RA; Birnbaum MJ
    J Clin Invest; 2010 Jul; 120(7):2267-70. PubMed ID: 20577046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of AMP-activated protein kinase in mechanism of metformin action.
    Zhou G; Myers R; Li Y; Chen Y; Shen X; Fenyk-Melody J; Wu M; Ventre J; Doebber T; Fujii N; Musi N; Hirshman MF; Goodyear LJ; Moller DE
    J Clin Invest; 2001 Oct; 108(8):1167-74. PubMed ID: 11602624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin in Oncology - How Far Is Its Repurposing as an Anticancer Drug?
    Pácal L; Kaňková K
    Klin Onkol; 2020; 33(2):107-113. PubMed ID: 32303131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Metformin - mechanisms of action and use for the treatment of type 2 diabetes mellitus].
    Grzybowska M; Bober J; Olszewska M
    Postepy Hig Med Dosw (Online); 2011 May; 65():277-85. PubMed ID: 21677353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin: Insights into its anticancer potential with special reference to AMPK dependent and independent pathways.
    Ikhlas S; Ahmad M
    Life Sci; 2017 Sep; 185():53-62. PubMed ID: 28755883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin and Its Immune-Mediated Effects in Various Diseases.
    Nojima I; Wada J
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of AMP-activated protein kinase by metformin protects human coronary artery endothelial cells against diabetic lipoapoptosis.
    Eriksson L; Nyström T
    Cardiovasc Diabetol; 2014 Nov; 13():152. PubMed ID: 25391818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism Underlying Metformin Action and Its Potential to Reduce Gastric Cancer Risk.
    Lan WH; Lin TY; Yeh JA; Feng CL; Hsu JT; Lin HJ; Kuo CJ; Lai CH
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin action on AMP-activated protein kinase: a translational research approach to understanding a potential new therapeutic target.
    Boyle JG; Salt IP; McKay GA
    Diabet Med; 2010 Oct; 27(10):1097-106. PubMed ID: 20854376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin--mode of action and clinical implications for diabetes and cancer.
    Pernicova I; Korbonits M
    Nat Rev Endocrinol; 2014 Mar; 10(3):143-56. PubMed ID: 24393785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer.
    Rozengurt E; Sinnett-Smith J; Kisfalvi K
    Clin Cancer Res; 2010 May; 16(9):2505-11. PubMed ID: 20388847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New perspectives for metformin in cancer therapy].
    Loubière C; Dirat B; Tanti JF; Bost F
    Ann Endocrinol (Paris); 2013 May; 74(2):130-6. PubMed ID: 23587351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin and cancer.
    Rizos CV; Elisaf MS
    Eur J Pharmacol; 2013 Apr; 705(1-3):96-108. PubMed ID: 23499688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-Like Growth Factor 1/Mammalian Target of Rapamycin and AMP-Activated Protein Kinase Signaling Involved in the Effects of Metformin in the Human Endometrial Cancer.
    Cai D; Sun H; Qi Y; Zhao X; Feng M; Wu X
    Int J Gynecol Cancer; 2016 Nov; 26(9):1667-1672. PubMed ID: 27654259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AMPK: a target for drugs and natural products with effects on both diabetes and cancer.
    Hardie DG
    Diabetes; 2013 Jul; 62(7):2164-72. PubMed ID: 23801715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin extends
    Chen J; Ou Y; Li Y; Hu S; Shao LW; Liu Y
    Elife; 2017 Oct; 6():. PubMed ID: 29027899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.